Synthesis and crystal structure of cytotoxic copper(II) complex with 1,10-phenanthroline-5,6-dione and isothiazole derivative

Oligopyridine based copper(II) complexes are of interest to scientists as possible anticancer agents due to promising cytotoxic and DNA binding/cleaving properties. In this study, copper(II) complex [Cu(phendione)L₂]·C₂H₅OH with 1,10-phenanthroline-5,6-dione (phendione) and 4,5-dichloro-isothiazole-3-carboxylic acid (HL) was synthesized and characterized by elemental analysis, IR-spectroscopy, X-ray powder diffraction and single-crystal X-ray diffraction. According to X-ray diffraction data, obtained compound is mononuclear complex with square pyramidal coordination environment of the central atom which is surrounded by two isothiazolate molecules and one phendione ligand. The X-ray diffraction data are confirmed by IR-spectroscopy data showing the presence of characteristic stretching vibration bands of the carbonyl and carboxyl groups of oligopyridine ligand and isothiazolate ions, respectively. Density functional theory (DFT) calculations for complex were carried out using the ADF software package to perform geometry optimization and frequency calculations that were in a good agreement with experimental IR spectrum. Cytotoxicity of complex and initial reagents was tested in vitro against HepG2 (human hepatocellular carcinoma) and MCF-7 (human breast adenocarcinoma) cell lines. The complex showed high dose-dependent cytotoxic activity with the IC₅₀ values of 0.60±0.03 µM and 0.96±0.13 µM, respectively, which is higher than the activity of cisplatin against these cell lines. The activity of the complex is due to the presence of phendione ligand, which exhibits a similar cytotoxic activity.

1. Bencini A., Lippolis V. 1 ,10-Phenanthroline: A versatile building block for the construction of ligands for various purposes. Coordination Chemistry Reviews. 2010;254(17):2096–2180. https://doi.org/10.1016/j.ccr.2010.04.008.

2. Krasnovskaya O., Naumov A., Guk D., Gorelkin P., Erofeev A., Beloglazkina E., et al. Copper coordination compounds as biologically active agents. International Journal of Molecular Sciences. 2020;21(11): 3965. https://doi.org/10.3390/ijms21113965.

3. Dey D., Roy A. B., Ranjani A., Gayathri L., Chandraleka S., Dhanasekaran D., et al. Synthesis and bio-catalytic activity of isostructural cobalt(III)-phenanthroline complexes. Journal of Chemical Sciences. 2015;127(4):649–661. https://doi.org/10.1007/s12039-015-0817-y.

4. Al-Omair M. A. Biochemical activities and electronic spectra of different cobalt phenanthroline complexes. Arabian Journal of Chemistry. 2019;12(7):1061– 1069. https://doi.org/10.1016/j.arabjc.2018.11.006.

5. Čongrádyová A., Jomová K., Kuckova L., Kožíšek J., Moncol’ J., Valko M. Antimicrobial activity of copper(II) complexes. Journal of Microbiology, Biotechnology and Food Sciences. 2014;3(1):67–70.

6. Mahalakshmi R., Raman N. A Therapeutic journey of mixed ligand complexes containing 1,10-phenanthroline derivatives: A review. International Journal of Current Pharmaceutical Research. 2016;8(3):1–6.

7. Viganor L., Howe O., McCarron P., McCann M., Devereux M. The antibacterial activity of metal complexes containing 1,10-phenanthroline: Potential as alternative therapeutics in the era of antibiotic resistance. Current Topics in Medicinal Chemistry. 2016;17(11):1280–1302. https://doi.org/10.2174/1568026616666161003143333.

8. Galindo-Murillo R., García-Ramos J. C., Ruiz-Azuara L., Cheatham T. E., Cortés-Guzmán F. Intercalation processes of copper complexes in DNA. Nucleic Acids Research. 2015;43(11):5364–5376. https://doi.org/10.1093/nar/gkv467.

9. Sigman D. S., Graham D. R., D'Aurora V., Stern A. M. Oxygen-dependent cleavage of DNA by the 1,10-phenanthroline.cuprous complex. Inhibition of Escherichia coli DNA polymerase I. Journal of Biological Chemistry. 1979;254(24):12269–12272.

10. Serment-Guerrero J., Bravo-Gomez M. E., Lara-Rivera E., Ruiz-Azuara L. Genotoxic assessment of the copper chelated compounds Casiopeinas: Clues about their mechanisms of action. Journal of Inorganic Biochemistry. 2017;166;68–75. https://doi.org/10.1016/j.jinorgbio.2016.11.007.

11. Bravo-Gómez M. E., Dávila-Manzanilla S., Flood-Garibay J., Muciño-Hernández M. Á., Mendoza Á., García-Ramos J. C., et al. Secondary ligand effects on the cytotoxicity of several Casiopeína’s group II compounds. Journal of the Mexican Chemical Society. 2012;56(1):85–92.

12. Tabti R., Tounsi N., Gaiddon C.,Bentouhami E., Désaubry L. Progress in copper complexes as anticancer agents. Medicinal Chemistry. 2017;7(5):875–879. https://doi.org/10.4172/2161-0444.1000445.

13. Kletskov A. V., Bumagin N. A., Zubkov F. I., Grudinin D. G., Potkin V. I. Isothiazoles in the design and synthesis of biologically active substances and ligands for metal complexes. Synthesis. 2020;52(2):159–188. https://doi.org/10.1055/s-0039-1690688.

14. Eremina J. A., Lider E. V., Sukhikh T. S., Klyushova L. S., Perepechaeva M. L., Sheven' D. G., et al. Water-soluble copper(II) complexes with 4,5-dichloro-isothiazole-3-carboxylic acid and heterocyclic N-donor ligands: Synthesis, crystal structures, cytotoxicity, and DNA binding study. Inorganica Chimica Acta. 2020;510. Article number 119778. https://doi.org/10.1016/j.ica.2020.119778.

15. Kaberdin R. V., Potkin V. I. Isothiazoles (1,2-thiazoles): synthesis, properties and applications. Russian Chemical Reviews. 2002;71(8):673–694.

16. De Oliveira Silva A., McQuade J., Szostak M. Recent Advances in the Synthesis and Reactivity of Isothiazoles. Advanced Synthesis and Catalysis. 2019;361(13):3050–3067. https://doi.org/10.1002/adsc.201900072.

17. Perdew J. P., Burke K., Ernzerhof M. Generalized gradient approximation made simple. Physical Review Letters. 1996;77(18):3865–3868. https://doi.org/10.1103/PhysRevLett.77.3865.

18. Van Lenthe E., Baerends E. J. Optimized Slater-type basis sets for the elements 1-118. Journal of Computational Chemistry. 2003;24(9):1142–1156. https://doi.org/10.1002/jcc.10255.

19. Sheldrick G. M. SHELXT – Integrated space-group and crystal-structure determination. Acta Crystallographica, Section A: Foundations of Crystallography. 2015;A71(1):3–8. https://doi.org/10.1107/S2053273314026370.

20. Sheldrick G. M. Crystal structure refinement with SHELXL. Acta Crystallographica, Section C: Structural Chemistry. 2015;C71(1):3–8. https://doi.org/10.1107/S20532296140242183.

21. Dolomanov O. V., Bourhis L. J., Gildea R. J., Howard J. A. K., Puschmann H. OLEX2: A complete structure solution, refinement and analysis program. Journal of Applied Crystallography. 2009;42(2):339– 341. http://dx.doi.org/10.1107/S0021889808042726.

22. Eremina J. A., Lider E. V., Kuratieva N. V., Samsonenko D. G., Klyushova L. S., Sheven' D. G., et al. Synthesis and crystal structures of cytotoxic mixed-ligand copper(II) complexes with alkyl tetrazole and polypyridine derivatives. Inorganica Chimica Acta. 2021;516. Article number 120169. https://doi.org/10.1016/j.ica.2020.120169.

23. Pearson R. G. Absolute electronegativity and hardness: applications to organic chemistry. Journal of Organic Chemistry. 1989;54(6):1423– 1430. https://doi.org/10.1021/jo00267a034.

24. Eremina J. A., Ermakova E. A., Smirnova K. S., Klyushova L. S., Berezin A. S., Sukhikh T. S., et al. Cu(II), Co(II), Mn(II) complexes with 5-phenyltetrazole and polypyridyl ligands: Synthesis, characterization and evaluation of the cytotoxicity and antimicrobial activity. Polyhedron. 2021;206. Article number 115352. https://doi.org/10.1016/j.poly.2021.115352.